undamentalytics Newsletter

Sagimet Biosciences Inc. valuation and forecast

Explore the models for Sagimet Biosciences Inc., adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: every model's value for Sagimet Biosciences Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.

Price vs value

Under review: limited reported history: available models are shown without a Buy/Hold/Sell rating. We'll show the comparison once resolved.

Analyst recommendations

12 analysts, Oct 2026
Buy1192%
Hold00%
Sell18%

Monthly trend

  1. Oct 202629112
  2. Sep 202629112
  3. Aug 202618110
  4. Jul 202618110

Counts of recommendations published by analysts covering Sagimet Biosciences Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Price history

Loading chart…

Third-party market data · may be delayed

SGMT valuation questions

How does Fundamentalytics value Sagimet Biosciences Inc.?
We use the models that fit Sagimet Biosciences Inc.'s business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved Invalid Date. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Sagimet Biosciences Inc.